Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 21;20(5):80.
doi: 10.3892/br.2024.1768. eCollection 2024 May.

Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)

Affiliations
Review

Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)

Cut Raihanah et al. Biomed Rep. .

Abstract

Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on in vivo and clinical trial studies.

Keywords: hyperandrogenism; isoflavone; menstrual cycle; ovarian morphology; polycystic ovary syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Pathophysiology of PCOS symptoms. Hyperandrogenism, a condition derived from both increasing the androgen level and lowering the sex hormone-binding globulin, is the main cause of other PCOS symptoms, including polycystic ovary morphology and irregular menstruation. The lowering of sex hormone-binding globulin is caused by hyperinsulinemia. Meanwhile, the increase in androgen levels is caused by the production of androgen in both the ovary and adrenal gland as a result of decreasing the activity of aromatase, which decreases the biosynthesis of oestradiol from testosterone. PCOS, polycystic ovary syndrome. The different colours in the testosterone structure refer to the OH bond (green), H bond (orange) and O bond (yellow). The structure at the right bottom refers to the process of converting testosterone to oestradiol by an aromatase catalyst. Steroids are composed of four fused rings (labelled A-D). Aromatase converts the ring labeled ‘A’ into an aromatic state.

Similar articles

Cited by

References

    1. Barbosa G, de Sá L, Rocha D, Arbex A. Polycystic ovary syndrome (PCOS) and infertility. Open J Endocr Metab Dis. 2016;6:58–65.
    1. Lentscher JA, Decherney AH. Clinical presentation and diagnosis of polycystic ovarian syndrome. Clin Obstet Gynecol. 2021;64:3–11. doi: 10.1097/GRF.0000000000000563. - DOI - PMC - PubMed
    1. Ma X, Li X, Ma L, Chen Y, He S. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF-κB signaling pathway. Bioengineered. 2021;12:7204–7212. doi: 10.1080/21655979.2021.1979864. - DOI - PMC - PubMed
    1. Harris HR, Titus LJ, Cramer DW, Terry KL. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2017;140:285–291. doi: 10.1002/ijc.30441. - DOI - PMC - PubMed
    1. Ashraf S, Nabi M, Rasool SUA, Rashid F, Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review. Egypt J Med Hum Genet. 2019;20(25)